Clinicopathological study of benign breast diseases a study of 50 cases

Manish Chaudhary, Purvesh Bhat, Vedant Wankhede, Jigar Aagja, Dhaval Rathva, Tushar Ahir


Background: Benign breast diseases are a neglected entity in developing countries despite the fact that they involved in the majority of breast complaints. Benign breast disorders can be defined as any non-malignant breast condition and involved wide range of clinical and pathological disorders. Breast diseases present as swellings. It is a symptom/sign for a different lesion varying from developmental abnormality, inflammatory lesions, epithelial and stromal proliferation to malignancy. Patients were studied on the basis of i.e., clinically, and histopathological ultrasound has done. Our purpose of study is to document various benign Brest diseases to study different mode of presentations of diseases and correlation of clinical and pathological diagnosis

Methods: The given study was a prospective and observational study, undertaken in the department of general surgery, govt. medical college Surat, during the study period of March 2018 to September 2019.All the female and male patients with breast related disease were included in this study. Female patients with biopsy proven malignancy were excluded from the study.

Results: The study comprised of 50 patients with benign breast diseases; the most common is Fibro adenoma which formed 68% then fibrocystic diseases 20%. With most common age group involved in our study is 21-30 years.

Conclusions: Benign breast diseases are more common but ignored entity though it carries majority of complaints and occur mainly in young women less than 30 years of age and were mostly fibro adenoma and fibrocystic change.


Breast cancer, Duct papilloma, Inflammation, Radiology

Full Text:



Breast-Definition of breast by Merriam-Webster". Available at: Accessed on 20 Jan 2020.

Santen RJ, Mansel R. Benign breast disorders. N Engl JMed. 2005;353(3):275-85.

Connolly JL, Schnitt SJ. Clinical and histologic aspects of proliferative and Non-proliferative benign breast disease. J Cell Biochem Suppl. 1993;17G:45-8.

Adesunkami AR, Agbakwuru EA. Benign breast disease at Wesley Guild Hospital, Ilesha, Nigeria. West Afr J Med. 2001;20(2):146-51.

Ihekwaba FN. Benign breast disease in Nigerian women: a study of 657 patients. J R Col Surg Edin. 1994;39(5):280-03.

Florica JV. Fibrocystic changes. O and G Clin N am. 1994;21(3):445-59.

Greenberg R, Skornick Y, Kaplan O. Management of breast fibroadenomas. J Gen Int Med. 1998;13:640-05.

Leis HP Jr. Commarata A, Laraja RD. Nipple discharge significant and treatment. Breast. 1985;11:6.

Sakorafas GH. Nipple discharge Current diagnostic and therapeutic approaches Cancer Treat Rev. 2001;27:275-82.

Chaikamont RT. Clinical breast examination, palpable breast lesion. J Med Assoc Thai. 2005;88(4):505-7.

Sainsbury RC. Breast In: Norman WS, Bulstrode CJK, P.Ronan O’Connel editors. Bailey and Love’s Short Practice of Surgery. 25th Ed. London: Edward Arnold Ltd. 2008;827-35.

Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative disease. N Engl J Med. 1985;312:146-51.

Foncroft LM, Evans EB, Hirst C, Hicks BJ. Presentation and diagnosis of adolescent breast disease. Breast. 2001;10(5):399-404.